HomeProductsBioactive CompoundsJAK/STAT SignalingFLT3Dovitinib
Chemical structure of CAS 405169-16-6

Dovitinib

CAS No.405169-16-6
MDL No.MFCD10565680
MFC21H21FN6O
MW392.40
InChI KeyPIQCTGMSNWUMAF-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone is an N-arylpiperazine.

CAS No.405169-16-6
Product NameDovitinib

Biological Targets

FGFR3·PDGFRB·PDGFRA·KIT·FLT3·

Associated Conditions

triple-negative breast cancer·glioblastoma multiforme·endometrial cancer·cancer·neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Tyrosine kinase inhibitors to treat liver cancer.

Expert opinion on emerging drugs • Vol. 15, Issue 1 • 2010
PMID: 20128706DOI: 10.1517/14728210903571659

Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors.

Journal of medicinal chemistry • Vol. 52, Issue 2 • 2009
PMID: 19113866DOI: 10.1021/jm800790t

A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 14, Issue 7 • 2008
PMID: 18381947DOI: 10.1158/1078-0432.CCR-07-1466

Gateways to clinical trials. July-August 2008.

Methods and findings in experimental and clinical pharmacology • Vol. 30, Issue 6 • 2008
PMID: 18850047

Documentation

Similar Products